Beckman Coulter Genomics Introduces a Scalable RNA-seq service line for processing intact and degraded RNA samples

Beckman Coulter Genomics, provider of expert sequencing solutions for research and healthcare institutions worldwide, has added stranded, ribodepletion and globin reduction library construction options to their existing RNA-Seq services. The Illumina* TruSeq Stranded Total RNA Sample Prep Kit has been automated on Beckman Coulter instruments to enable scalability and LIMS sample tracking. This expanded offering has been validated at Beckman Coulter Genomics for human, mouse, rat and plant samples. In addition it includes the ability to work with samples derived from blood and FFPE.

This fully automated sample preparation pipeline delivers consistent results run after run, reducing user variability and bias and allows processing of a large amount of samples with reduced turnaround time relative to manual library construction.

This technology provides a robust and highly scalable end-to-end solution for whole transcriptome analysis that is accurate, sensitive and integrated with Illumina sequencing platforms, said Tim Anderson, vice president and general manager of genomic services.

Providing the clearest, most complete view of the transcriptome, there is a high level of confidence in the discovery of alternative transcripts, antisense expression, and allele-specific expression.

“This new Stranded RNA Sequencing pipeline delivers a more comprehensive transcriptome analysis including the ability to resolve overlapping genes and the identification of ncRNA and antisense transcripts,” said John Battles, senior manager, bioinformatics and study management at Beckman Coulter Genomics. “We are excited by this new addition to our already robust bioinformatics analysis DNASeq and RNASeq pipelines.”

This expanded offering is suited for genome annotation, de novo transcriptome assembly, and accurate digital gene expression analysis thus providing uniform coverage and precise measurement of strand orientation, and discovery across both coding and multiple forms of non-coding RNA.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

Sign in to keep reading

We're committed to providing free access to quality science. By registering and providing insight into your preferences you're joining a community of over 1m science interested individuals and help us to provide you with insightful content whilst keeping our service free.

or

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
MGI Tech joins forces with SAMRC and DSTI to launch South Africa’s 110K Human Genome Program and unveil Africa’s first DNBSEQ-T7, ushering in a new era in African genomics